The orthopedic biomaterials market is expected to register a CAGR of 10.5% during the assessment period of 2020 to 2027, to reach USD 40,519.52 million by 2027. Biomaterials are extensively used for manufacturing implants as they do not evoke immunological reactions. The growth of the orthopedic branch of medicine coupled with rising demand for biomaterials for implants is likely to...